194 related articles for article (PubMed ID: 26376302)
1. Human Acid β-Glucosidase Inhibition by Carbohydrate Derived Iminosugars: Towards New Pharmacological Chaperones for Gaucher Disease.
Parmeggiani C; Catarzi S; Matassini C; D'Adamio G; Morrone A; Goti A; Paoli P; Cardona F
Chembiochem; 2015 Sep; 16(14):2054-64. PubMed ID: 26376302
[TBL] [Abstract][Full Text] [Related]
2. Rapid modifications of N-substitution in iminosugars: development of new β-glucocerebrosidase inhibitors and pharmacological chaperones for Gaucher disease.
Cheng WC; Weng CY; Yun WY; Chang SY; Lin YC; Tsai FJ; Huang FY; Chen YR
Bioorg Med Chem; 2013 Sep; 21(17):5021-8. PubMed ID: 23880081
[TBL] [Abstract][Full Text] [Related]
3. A systematic investigation of iminosugar click clusters as pharmacological chaperones for the treatment of Gaucher disease.
Joosten A; Decroocq C; de Sousa J; Schneider JP; Etamé E; Bodlenner A; Butters TD; Compain P
Chembiochem; 2014 Jan; 15(2):309-19. PubMed ID: 24375964
[TBL] [Abstract][Full Text] [Related]
4. Docking study and biological evaluation of pyrrolidine-based iminosugars as pharmacological chaperones for Gaucher disease.
Kato A; Nakagome I; Sato K; Yamamoto A; Adachi I; Nash RJ; Fleet GW; Natori Y; Watanabe Y; Imahori T; Yoshimura Y; Takahata H; Hirono S
Org Biomol Chem; 2016 Jan; 14(3):1039-48. PubMed ID: 26633162
[TBL] [Abstract][Full Text] [Related]
5. Glucocerebrosidase inhibitors for the treatment of Gaucher disease.
Trapero A; Llebaria A
Future Med Chem; 2013 Apr; 5(5):573-90. PubMed ID: 23573974
[TBL] [Abstract][Full Text] [Related]
6. Polyhydroxylated bicyclic isoureas and guanidines are potent glucocerebrosidase inhibitors and nanomolar enzyme activity enhancers in Gaucher cells.
Trapero A; Alfonso I; Butters TD; Llebaria A
J Am Chem Soc; 2011 Apr; 133(14):5474-84. PubMed ID: 21413704
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of multimeric pyrrolidine iminosugar inhibitors of human β-glucocerebrosidase and α-galactosidase A: First example of a multivalent enzyme activity enhancer for Fabry disease.
Martínez-Bailén M; Carmona AT; Cardona F; Matassini C; Goti A; Kubo M; Kato A; Robina I; Moreno-Vargas AJ
Eur J Med Chem; 2020 Apr; 192():112173. PubMed ID: 32146376
[TBL] [Abstract][Full Text] [Related]
8. Inhibitor versus chaperone behaviour of d-fagomine, DAB and LAB sp(2)-iminosugar conjugates against glycosidases: A structure-activity relationship study in Gaucher fibroblasts.
Mena-Barragán T; García-Moreno MI; Nanba E; Higaki K; Concia AL; Clapés P; García Fernández JM; Ortiz Mellet C
Eur J Med Chem; 2016 Oct; 121():880-891. PubMed ID: 26361824
[TBL] [Abstract][Full Text] [Related]
9. Exploring substituent diversity on pyrrolidine-aryltriazole iminosugars: Structural basis of β-glucocerebrosidase inhibition.
Martínez-Bailén M; Carmona AT; Patterson-Orazem AC; Lieberman RL; Ide D; Kubo M; Kato A; Robina I; Moreno-Vargas AJ
Bioorg Chem; 2019 May; 86():652-664. PubMed ID: 30825709
[TBL] [Abstract][Full Text] [Related]
10. Probing the Inhibitor versus Chaperone Properties of sp²-Iminosugars towards Human β-Glucocerebrosidase: A Picomolar Chaperone for Gaucher Disease.
Mena-Barragán T; García-Moreno MI; Sevšek A; Okazaki T; Nanba E; Higaki K; Martin NI; Pieters RJ; Fernández JMG; Mellet CO
Molecules; 2018 Apr; 23(4):. PubMed ID: 29673163
[TBL] [Abstract][Full Text] [Related]
11. Rational design and synthesis of highly potent pharmacological chaperones for treatment of N370S mutant Gaucher disease.
Wang GN; Reinkensmeier G; Zhang SW; Zhou J; Zhang LR; Zhang LH; Butters TD; Ye XS
J Med Chem; 2009 May; 52(10):3146-9. PubMed ID: 19397268
[TBL] [Abstract][Full Text] [Related]
12. Multivalent pyrrolidines acting as pharmacological chaperones against Gaucher disease.
Borie-Guichot M; Lan Tran M; Garcia V; Oukhrib A; Rodriguez F; Turrin CO; Levade T; Génisson Y; Ballereau S; Dehoux C
Bioorg Chem; 2024 May; 146():107295. PubMed ID: 38513326
[TBL] [Abstract][Full Text] [Related]
13. Structure of acid beta-glucosidase with pharmacological chaperone provides insight into Gaucher disease.
Lieberman RL; Wustman BA; Huertas P; Powe AC; Pine CW; Khanna R; Schlossmacher MG; Ringe D; Petsko GA
Nat Chem Biol; 2007 Feb; 3(2):101-7. PubMed ID: 17187079
[TBL] [Abstract][Full Text] [Related]
14. Hydrophilic iminosugar active-site-specific chaperones increase residual glucocerebrosidase activity in fibroblasts from Gaucher patients.
Chang HH; Asano N; Ishii S; Ichikawa Y; Fan JQ
FEBS J; 2006 Sep; 273(17):4082-92. PubMed ID: 16934036
[TBL] [Abstract][Full Text] [Related]
15. Chaperone activity of bicyclic nojirimycin analogues for Gaucher mutations in comparison with N-(n-nonyl)deoxynojirimycin.
Luan Z; Higaki K; Aguilar-Moncayo M; Ninomiya H; Ohno K; García-Moreno MI; Ortiz Mellet C; García Fernández JM; Suzuki Y
Chembiochem; 2009 Nov; 10(17):2780-92. PubMed ID: 19830760
[TBL] [Abstract][Full Text] [Related]
16. Glucosylceramide mimics: highly potent GCase inhibitors and selective pharmacological chaperones for mutations associated with types 1 and 2 Gaucher disease.
Schönemann W; Gallienne E; Ikeda-Obatake K; Asano N; Nakagawa S; Kato A; Adachi I; Górecki M; Frelek J; Martin OR
ChemMedChem; 2013 Nov; 8(11):1805-17. PubMed ID: 24115322
[TBL] [Abstract][Full Text] [Related]
17. Selective Targeting of the Interconversion between Glucosylceramide and Ceramide by Scaffold Tailoring of Iminosugar Inhibitors.
Baudoin-Dehoux C; Castellan T; Rodriguez F; Rives A; Stauffert F; Garcia V; Levade T; Compain P; Génisson Y
Molecules; 2019 Jan; 24(2):. PubMed ID: 30669468
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of N-substituted ε-hexonolactams as pharmacological chaperones for the treatment of N370S mutant Gaucher disease.
Wang GN; Twigg G; Butters TD; Zhang S; Zhang L; Zhang LH; Ye XS
Org Biomol Chem; 2012 Apr; 10(15):2923-7. PubMed ID: 22286559
[TBL] [Abstract][Full Text] [Related]
19. Glucocerebrosidase (GCase) activity modulation by 2-alkyl trihydroxypiperidines: Inhibition and pharmacological chaperoning.
Clemente F; Matassini C; Faggi C; Giachetti S; Cresti C; Morrone A; Paoli P; Goti A; Martínez-Bailén M; Cardona F
Bioorg Chem; 2020 May; 98():103740. PubMed ID: 32200326
[TBL] [Abstract][Full Text] [Related]
20. N- and C-alkylation of seven-membered iminosugars generates potent glucocerebrosidase inhibitors and F508del-CFTR correctors.
Désiré J; Mondon M; Fontelle N; Nakagawa S; Hirokami Y; Adachi I; Iwaki R; Fleet GW; Alonzi DS; Twigg G; Butters TD; Bertrand J; Cendret V; Becq F; Norez C; Marrot J; Kato A; Blériot Y
Org Biomol Chem; 2014 Nov; 12(44):8977-96. PubMed ID: 25277226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
